Company Encyclopedia
View More
name
Omada Health
OMDA.US
Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.
376.32 B
OMDA.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Omada Health (NASDAQ:OMDA) Trading Down 5.1% - What's Next?

    Omada Health (NASDAQ:OMDA) shares fell 5.1% on Monday, trading as low as $16.47. The stock's trading volume was down 40% from the average. Analysts have mixed ratings: Weiss Ratings suggests a "sell," while others like Barclays and BMO Capital Markets have "overweight" and "buy" ratings, respectively. The consensus target price is $26.33. Institutional investors have recently acquired stakes in the company. Despite a Moderate Buy rating, some analysts suggest better investment opportunities elsewhere.

    Market Beat·
    US
    OMDA
    -10.52%
    Market Beat·
    US
    OMDA
    -10.52%

    Franklin Resources Inc. Makes New Investment in Omada Health, Inc. $OMDA

    Franklin Resources Inc. acquired 147,251 shares of Omada Health, Inc., valued at $2,695,000, during Q2. Analysts have given Omada Health a "Moderate Buy" rating, with price targets ranging from $26 to $29. Despite this, the stock is trading down 12.6% at $16.13. Several other institutional investors also purchased stakes in Omada Health during the same period.

    Market Beat·
    US
    OMDA
    -10.52%
    US
    BEN
    -1.20%
    Market Beat·
    US
    OMDA
    -10.52%
    US
    BEN
    -1.20%

    Omada Health, Inc.'s (NASDAQ:OMDA) Lock-Up Period To End on December 3rd

    Omada Health's lock-up period ends on December 3rd, allowing insiders and major shareholders to sell shares. The company issued 7.9 million shares in its IPO at $19 each, totaling $150.1 million. Analysts have mixed ratings, with a consensus of "Moderate Buy" and a target price of $26.33. Recent institutional investments include stakes by Raymond James Financial, Strs Ohio, and others. Omada Health aims to inspire lasting health changes. Despite a "Moderate Buy" rating, top analysts suggest better stock options.

    Market Beat·
    US
    OMDA
    -10.52%
    Market Beat·
    US
    OMDA
    -10.52%

    Omada Health to Participate in Evercore Healthcare Conference

    SAN FRANCISCO, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Omada Health ( Nasdaq: OMDA ) , the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8th Annual Evercore Healthcare Conference, taking place in Miami, including a fireside chat ...

    GlobeNewswire·
    US
    OMDA
    -10.52%
    GlobeNewswire·
    US
    OMDA
    -10.52%

    Evercore ISI Sticks to Their Buy Rating for Omada Health, Inc. (OMDA)

    Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Omada Health, Inc. with a price target of $28.00. The shares closed at $19.46. Anderson has an average return of -2.4% and a 47.80% success rate. Morgan Stanley also issued a Buy rating, while TR reiterated a Hold rating on Omada Health, Inc.

    Tip Ranks·
    US
    OMDA
    -10.52%
    Tip Ranks·
    US
    OMDA
    -10.52%
    © 2025 Longbridge｜Disclaimer